Progesterone Capsule
Product Images NDC 82804-268

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 82804-268). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph1 (Figure01)

This text contains information about a study evaluating the effects of Conjugated Estrogens alone, Conjugated Estrogens plus Micronized Progesterone (cyclical), and Placebo. The data shows the number of patients remaining at different time intervals over 36 months. The study included a total of 358 patients at the beginning.*

FDA Label Image

82804-268-30 (Image 01)

This is a description of Progesterone capsules, each containing 200mg of micronized progesterone. The medication is in the form of oval white, opaque capsules, imprinted with P-4. It is important not to use this medication if allergic to peanuts. The capsules are packaged by Proficient Rx LP in Thousand Oaks, CA. The product is identified by the NDC 82804-268-30 and has an expiration date of 00/00/00. It is advised to store the medication at 20°-25°C (58°-77°F) and keep it out of the reach of children. Made in India by Mir. For. Bionphamma Inc., the capsules are available in a pack of 30.*

FDA Label Image

Chemical Structure (Structure01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.